Senior Director, Global Clinical Finance, Budgeting Outsourcing

Company Overview

Immunity Bio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates NK cells, T cells, and memory T cells for a long-duration response.

The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.

Immunity Bio is a vertically integrated commercial stage biotechnology company developing next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. The Company’s range of immunotherapy and cell therapy platforms, alone and together, act to drive and sustain an immune response with the goal of creating durable and safe protection against disease. Designated an FDA Breakthrough Therapy, ANKTIVA is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS that activates NK cells, T cells, and memory T cells for a long-duration response.

The Company is applying its science and platforms to treating cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate the need for standard high-dose chemotherapy. These platforms and their associated product candidates are designed to be more effective, accessible, and easily administered than current standards of care in oncology and infectious diseases.

• Immunity Bio is developing cutting-edge technology with the goal to transform the lives of patients with cancer and develop next-generation therapies and vaccines that complement, harness and amplify the immune system to defeat cancers and infectious diseases.
• Opportunity to join a publicly traded biopharmaceutical company with headquarters in Southern California.
• Work with a collaborative team with the ability to work across different areas of the company.
• Ability to join a growing company with professional development opportunities.

The Senior Director, Global Clinical Finance, Budgeting & Outsourcing provides enterprise leadership for the financial and commercial management of global clinical development. The role establishes portfolio strategy, governance, operating standards and decision frameworks across trial budgeting, forecasting, outsourcing, contracting and supplier management. As a senior advisor to Clinical Development leadership, the position provides forward-looking visibility into clinical spend, supplier performance and material financial or contractual risk, and leads cross-functional initiatives that improve value, transparency, compliance and execution.

• Define and lead the global clinical finance, budgeting and outsourcing strategy, operating model and multi-year capability roadmap in alignment with Clinical Development and enterprise priorities.
• Lead portfolio-level financial planning and oversight across clinical programs, including long-range forecasts, scenario analyses, financial controls, accrual methodologies, variance management and executive reporting, in partnership with Finance and Accounting.
• Provide executive leadership with forward-looking assessment of clinical spend, financial commitments, forecast risk, operational trade-offs and opportunities for cost optimization or avoidance.
• Establish global outsourcing and category strategies across CROs, investigative…